FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely, oncology, and can be used to treat cervical cancer (CC). In the preoperative period, two courses of regional chemotherapy are carried out with an interval of 3 weeks according to the following scheme: a) on the first day before and after the intra-arterial administration of cisplatin, hyperhydration is performed according to the scheme: 2.0 L 0.9 % NaCl supplemented with 20 mM KCl, solution of sodium chloride 400 ml of 0.9 % or 5 % dextrose, furosemide 40 mg (2.0), antiemetics, then intra-arterially administered cisplatin at a dose of 75 mg/m2 on 400 ml of physiological solution, the administration of cisplatin is performed alternately in the right and left uterine arteries by 200.0 ml of the prepared solution at a rate of 3–4 ml/min; b) the next day, premedication is performed according to the following scheme: 12 and 6 hours before the administration of paclitaxel, 20 mg of dexamethasone is administered intramuscularly, 30–60 minutes before the administration of paclitaxel, 50 mg of diphenhydramine, 300 mg of cimetidine or 50 mg of ranitidine are intravenously administered intravenously, paclitaxel is then given intravenously at a dose of 175 mg/m2 in the form of a 3-hour infusion, diluted to a concentration of 0.3–1.2 mg/ml with a solution of 0.9 % sodium chloride or 5 % dextrose solution. Invention makes it possible to create the maximum concentration of the cytostatic directly in the tumor tissue and simultaneously realize the systemic effect of chemotherapy, as a result of which resorption of the tumor takes place and the process is translated into a resectable state.
EFFECT: effect of reducing the volume of the tumor, reducing the pain syndrome and the absence of previously available blood discharges from the genital tract is achieved.
1 cl, 4 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF THE TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER OF IB3-IIIB STAGES | 2022 |
|
RU2799247C2 |
METHOD FOR COMBINED TREATMENT OF LOCALLY ADVANCED FORMS OF CERVICAL CANCER IIB-IIIB (T2B-T3BN0(1)M0) STAGES | 2020 |
|
RU2748135C2 |
METHOD OF TREATMENT OF INOPERABLE SQUAMOUS CELL CARCINOMA OF HEAD AND NECK | 2023 |
|
RU2806512C1 |
METHOD OF TREATING CERVICAL CANCER USING CHEMOEMBOLISATION OF UTERINE ARTERIES WITH PLATINUM DRUGS | 2015 |
|
RU2583144C1 |
METHOD OF NEOADJUVANT TREATMENT OF PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER | 2017 |
|
RU2648642C1 |
METHOD OF COMBINED TREATMENT OF MUSCULO-INVASIVE BLADDER CANCER T3-T4 N0-+M0 | 2019 |
|
RU2713443C2 |
METHOD FOR COMBINED NEOADJUVANT POLYCHEMOTHERAPY OF CERVICAL CANCER PATIENTS | 2015 |
|
RU2595855C1 |
METHOD FOR PREOPERATIVE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER AT T1b2-T2b STAGE | 2016 |
|
RU2613888C1 |
CERVICAL CANCER NEOADJUVANT CHEMOTHERAPY METHOD | 2009 |
|
RU2405544C1 |
METHOD FOR TREATING THE CASES OF URINARY BLADDER CANCER | 2005 |
|
RU2276605C1 |
Authors
Dates
2018-10-31—Published
2017-03-22—Filed